Loading clinical trials...
Loading clinical trials...
A Phase 1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Sequential Dose Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease on Donepezil
Conditions
Interventions
ASP0777
Placebo
Locations
2
United States
Pacific Research Network, Inc.
San Diego, California, United States
MD Clinical
Hallandale, Florida, United States
Start Date
June 16, 2011
Primary Completion Date
November 4, 2011
Completion Date
November 4, 2011
Last Updated
October 30, 2024
NCT07033494
NCT06159673
NCT07457138
NCT07214727
NCT07422857
NCT06584357
Lead Sponsor
Astellas Pharma Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions